TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02729
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Comprehensive Analysis of TCR-β Repertoire in Patients With Neurological Immune-Mediated Disorders

Scientific Reports
Multidisciplinary
2019English

Serum microRNA-205 as a Novel Biomarker for Cervical Cancer Patients

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Cervical Cancer Systemic Inflammation Score: A Novel Predictor of Prognosis

Oncotarget
Oncology
2016English

Narrowed TCR Repertoire and Viral Escape as a Consequence of Heterologous Immunity

Journal of Clinical Investigation
Medicine
2007English

Preservation of Immune Function in Cervical Cancer Patients During Chemoradiation Using a Novel Integrative Approach

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2010English

Ligation-Anchored PCR Unveils Immune Repertoire of TCR-beta From Whole Blood

BMC Biotechnology
Biotechnology
2015English

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer

Frontiers in Immunology
AllergyImmunology
2019English

A Novel Biomarker for Cervical Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy